Over the last couple of years, one of the best pharma stocks to own has been Eli Lilly ( LLY 14.56%). But now, an investment in Lilly may not look so enticing as the possibility of more tariffs loom. Let's explore how tariffs would impact Eli Lilly's business, and assess whether investors should buy the stock now or run for the hills instead.

The first GLP-1 pill could be in medicine cabinets sooner than expected. Eli Lilly (LLY) announced Thursday that its daily obesity pill, orforglipron, met company goals in the first of several late-stage trials — helping patients with Type 2 diabetes lower their blood sugar while causing weight loss.